CSL shrugs off coronavirus hit
Biotechnology giant CSL is experiencing some disruption due to the coronavirus as well as deploying its capabilities in the fight against the disease according to a market update. The Melbourne company told investors that expertise in three areas was being deployed to support the global response to the Covid-19 coronavirus. Immunological science, vaccinology and protein…